TWO scientists in the US Food and Drug Administration's (FDA's) Office of Vaccines Research and Review created a cost-effective step in the manufacture of a meningitis vaccine called MenAfriVac, earning the FDA a 2016 Patents for Humanity Award for Impact on Global Public Health, and leading to more than 235 million lives being protected by the vaccine.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jan 17
